Five Themes For Korean Biopharma In 2025

US Approvals, New Modalities, Obesity

 
• By Jung Won Shin
  
Scrip Perspectives - new chapter
Korean Industry Entering A New Growth Chapter Despite Political Uncertainties (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Scrip Perspectives